Psoriasis Therapy Has Mixed Effects on Cardiovascular Risk Factors

(MedPage Today) -- BOSTON -- An evaluation of a common psoriasis drug's effect on one cardiometabolic risk factor instead showed a favorable impact on a different one. The randomized trial showed that apremilast (Otezla) did not significantly...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news